MedPath
HSA Approval

GLIOTEM 20 CAPSULE 20 MG

SIN15641P

GLIOTEM 20 CAPSULE 20 MG

GLIOTEM 20 CAPSULE 20 MG

March 1, 2019

RANBAXY (MALAYSIA) SDN. BHD.

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantRANBAXY (MALAYSIA) SDN. BHD.
Licence HolderRANBAXY (MALAYSIA) SDN. BHD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

L01AX03

temozolomide

Manufacturer Information

RANBAXY (MALAYSIA) SDN. BHD.

Sun Pharmaceutical Industries Limited.

Active Ingredients

Temozolomide

20.000 mg

Temozolomide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

GLIOTEM 20 CAPSULE 20 MG - HSA Approval | MedPath